Skip to main content
Log in

Effect of long-term colchicine therapy on jejunal mucosa

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Colchicine is recommended as daily prophylactic therapy in patients with familial mediterranean fever (FMF) to prevent febrile paroxysms. The drug is known to be a potent inhibitor of mitotic activity and might therefore be expected to have a significant adverse effect on tissues that undergo rapid turnover. We studied small bowel biopsies from nine patients with FMF who were receiving daily low-dose oral colchicine therapy. In each patient the lengths of 20 crypts and villi were measured and the number of mitotic figures in 20 crypts were counted. The data were compared with similar measurements from histologically normal-appearing biopsies obtained from 14 patients with a variety of mild gastrointestinal complaints. The mean crypt length was found to be significantly greater (0.197 mm vs 0.186 mm,P<0.0001) and the mean villous length significantly smaller (0.369 mm vs. 0.442 mm,P<0.0001) in the FMF patients than in the control population. In addition, the mean number of mitotic figures per crypt was significantly higher in the FMF patients (2.58 vs 1.00,P<0.001). The data reveal a pattern of mucosal injury in the colchicine-treated FMF patients characterized by a hyperplastic crypt-villous atrophy pattern with increased mitotic rate, which is indicative of an increase in cell turnover and opposite to what we anticipated based on colchicine's known effect on mitotic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zemer D, Revach M, Mordechai P, Modan B, Schor S, Sohar E, Gafni J: Controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934, 1974

    Google Scholar 

  2. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW: Colchicine therapy for familial Mediterranean fever—a double-blind trial. N Engl J Med 291:934–937, 1974

    Google Scholar 

  3. Goldstein RC, Schwabe AD: Prophylactic colchicine therapy in familial Mediterranean fever—a controlled, double-blind study. Ann Intern Med 81:792–794, 1974

    Google Scholar 

  4. Eliakim M, Levy M, Ehrenfeld M: Recurrent polyserositis (familial Mediterranean fever, periodic disease). Amsterdam, Elsevier/North Holland Medical Press, 1981

    Google Scholar 

  5. Zemer D, Pras M, Sohar E, Gafni J: Colchicine in familial Mediterranean fever. N Engl J Med 294:170–171, 1976 (letter)

    Google Scholar 

  6. Levy M, Eliakim M: Long0term colchicine prophylaxis in familial Mediterranean fever. Br Med J 24:808, 1977

    Google Scholar 

  7. Bakir F: Periodic peritonitis. Present management and future prospects. Arch Intern Med 139:781–783, 1979

    Google Scholar 

  8. Peters RS, Lehman TJA, Schwabe AD: Colchicine use for familial Mediterranean fever. Observations associated with long-term treatment. West J Med 138:43–46, 1983

    Google Scholar 

  9. Merlin HE: Azoospermia caused by colchicine. A case report. Fertil Steril 23:180–181, 1972

    Google Scholar 

  10. Race TF, Paes IC, Faloon WW: Intestinal malabsorption induced by oral colchicine. Am J Med Sci 259:32–41, 1970

    Google Scholar 

  11. Webb DI, Chodos RB, Mahar CQ, Faloon WW: Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N Engl J Med 279:845–850, 1968

    Google Scholar 

  12. Brandborg LL, Rubin CE, Quinton WE: A multipurpose instrument for suction biopsy of the esophagus, stomach, small bowel and colon. Gastroenterology 37:1–16, 1959

    Google Scholar 

  13. Yu TF, Gutman AB: Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med 55:179–192, 1961

    Google Scholar 

  14. Bremner WJ, Paulsen CA: Colchicine and testicular function in man. N Engl J Med 294:1384–1385, 1976

    Google Scholar 

  15. Cohen MM, Levy M, Eliakim M: A cytogenetic evaluation of long-term colchicine therapy in the treatment of familial Mediterranean fever (FMF). Am J Med Sci 274:147–152, 1977

    Google Scholar 

  16. Shiner M, Doniach I: Histopathologic studies in steatorrhea. Gastroenterology 38:419–440, 1960

    Google Scholar 

  17. Ehrenfeld M, Levy M, Sharon P, Rachmilewitz D, Eliakim M: Gastrointestinal effects of long-term Colchine therapy in patients with recurrent polyseositis (familial Mediterranean fever). Dig Dis Sci 27:723–726, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, J., Lewin, K.J., Peters, R.S. et al. Effect of long-term colchicine therapy on jejunal mucosa. Digest Dis Sci 38, 2017–2021 (1993). https://doi.org/10.1007/BF01297078

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01297078

Key Words

Navigation